Upgrade to SI Premium - Free Trial

RedHill Biopharma (RDHL)

0.72 +0.01 (1.41%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (12/1/26)

Latest Headlines

RedHill acquires Ferring's Rebyota and Clenpiq for $12M upfront September 1, 2026 7:00 AM - StreetInsider RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring’s Rebyota® and Clenpiq® September 1, 2026 7:00 AM - StreetInsider RedHill sells Talicia to Apotex for $18M upfront plus milestones August 31, 2026 7:01 AM - StreetInsider RedHill seeks Ebola treatment role for opaganib as cases top 3,200 July 28, 2026 7:02 AM - StreetInsider Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development July 28, 2026 7:00 AM - PR NewsWire RedHill Biopharma closes $6M private placement with warrant upside June 22, 2026 4:10 PM - StreetInsider RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement June 22, 2026 4:10 PM - PR NewsWire RedHill Biopharma sets $6M private placement with warrant upside June 18, 2026 8:00 AM - StreetInsider RedHill Biopharma Announces Up To $19.4 Million Private Placement June 18, 2026 8:00 AM - PR NewsWire RedHill initiates enforcement of $10.9 million judgment in Korea June 8, 2026 7:01 AM - StreetInsider RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo June 8, 2026 7:00 AM - PR NewsWire Full Article List